Market Cap | ₹56,957Cr |
ROE | 14.89% |
P/E Ratio(TTM) | 75.56 |
EPS(TTM) | 26.71 |
P/B Ratio | 6.44 |
Dividend Yield | 0.12% |
Industry P/E | 35.33 |
Book Value | 313.59 |
Debt to Equity | 0.28 |
Face Value | 1 |
Parent Organisation | Glenmark Pharmaceuticals Limited |
Managing Director | Mr. Glenn Saldanha |
NSE Symbol | GLENMARK |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Sun Pharmaceutical Industries | NA (0.00%) | 37.73 | ||
Cipla | NA (0.00%) | 22.89 | ||
Dr Reddy's Laboratories | NA (0.00%) | 19.22 | ||
Mankind Pharma | NA (0.00%) | 55.88 |